Would love to sit down with Mr. Feuerstein and have a brief discussion of the primary, secondary, and tertiary structures of enzyme proteins, and just how those get mis-folded in dysfunctional rough endoplasmic reticula, disjointed from neuron mitochondria.
I bet the Chief Medical Officers of the failed clinical trials (91%) could talk circles around you too--and what good did it do?
How many posts have you seen where avxl has been valued at $25? $50? $100? Are they more right than the man who values it at $1? The Market thinks not.